Sign in

CIK 0001935979

  • Large accelerated filer

Biohaven Ltd.

Sign in to watch
Ticker
BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Virgin Islands, British
Entity type
Operating
Phone
+1 203-404-0410
Business address
215 CHURCH STREET, NEW HAVEN, CT, 06510
Former names
Biohaven Research Ltd.
  1. 4 Open-market buy Director bought 17,817 shares at $22.57 ($402,094)
  2. 4 Open-market buy Director bought 50,000 shares at $18.44 ($922,180)
  3. 4 Open-market buy Director bought 100,000 shares at $19.78 ($1,978,430)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Open-market buy Director bought 3,709,819 shares at $10.50 ($38,953,100)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chief Executive Officer bought 25,800 shares at $15.97 ($411,995)
  14. 4 Open-market buy Chief Executive Officer bought 141,930 shares at an average $14.84 ($2,105,772)
  15. 4 Open-market buy Director bought 200,000 shares at $10.50 ($2,100,000)
  16. 4 Open-market buy Chief Executive Officer bought 853,380 shares at $10.50 ($8,960,490)
  17. 4 Open-market buy Director bought 3,900,000 shares at $10.50 ($40,950,000)
  18. 4 Open-market buy Chief Financial Officer bought 142,857 shares at $10.50 ($1,499,999)
  19. 4 Open-market buy Director bought 9,523 shares at $10.50 ($99,992)
  20. 4/A Other acquisition Chief Executive Officer acquired 0 shares (other)

Page 5 of 7 · 130 filings